{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T05:38:25Z","timestamp":1792906705560,"version":"4.5.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005090","name":"Beijing Nova Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005090","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.micpath.2026.108895","type":"journal-article","created":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T01:19:49Z","timestamp":1792718389000},"page":"108895","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Activity of OPC-167832 against Mycobacterium abscessus and Mycobacterium chelonae: In vitro, intracellular, and in vivo assessment using a zebrafish infection model"],"prefix":"10.1016","volume":"221","author":[{"given":"Siyi","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyan","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzhen","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanfei","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7308-8942","authenticated-orcid":false,"given":"Bo","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hairong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.micpath.2026.108895_bib1","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.3201\/eid2311.170959","article-title":"Pulmonary versus nonpulmonary nontuberculous mycobacteria, Ontario, Canada","volume":"23","author":"Brode","year":"2017","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.micpath.2026.108895_bib2","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.thorsurg.2018.09.006","article-title":"Nontuberculous mycobacteria: epidemiology and the impact on pulmonary and cardiac disease","volume":"29","author":"Drummond","year":"2019","journal-title":"Thorac. Surg. Clin."},{"key":"10.1016\/j.micpath.2026.108895_bib3","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.3201\/eid2406.172095","article-title":"Pulmonary infections with nontuberculous mycobacteria, Catalonia, Spain, 1994-2014","volume":"24","author":"Santin","year":"2018","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.micpath.2026.108895_bib4","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jinf.2016.08.020","article-title":"The prevalence of non-tuberculous mycobacterial infections in mainland China: systematic review and meta-analysis","volume":"73","author":"Yu","year":"2016","journal-title":"J. Infect."},{"key":"10.1016\/j.micpath.2026.108895_bib5","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1164\/rccm.200604-571ST","article-title":"An official ATS\/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases","volume":"175","author":"Griffith","year":"2007","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.micpath.2026.108895_bib6","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1093\/jac\/dkr578","article-title":"Mycobacterium abscessus: a new antibiotic nightmare","volume":"67","author":"Nessar","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.micpath.2026.108895_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms9030596","article-title":"Phage therapy for Mycobacterium Abscessus and strategies to improve outcomes","volume":"9","author":"Hashemi Shahraki","year":"2021","journal-title":"Microorganisms"},{"key":"10.1016\/j.micpath.2026.108895_bib8","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.3201\/eid1909.120898","article-title":"Mycobacterium chelonae abscesses associated with biomesotherapy, Australia, 2008","volume":"19","author":"Ivan","year":"2013","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.micpath.2026.108895_bib9","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1590\/S0034-89102008000100020","article-title":"Outbreak of persistent cutaneous abscesses due to Mycobacterium chelonae after mesotherapy sessions, Lima, Peru","volume":"42","author":"Munayco","year":"2008","journal-title":"Rev. Saude Publica"},{"key":"10.1016\/j.micpath.2026.108895_bib10","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1007\/s40265-022-01817-w","article-title":"The struggle to end a millennia-long pandemic: novel candidate and repurposed drugs for the treatment of tuberculosis","volume":"82","author":"Edwards","year":"2022","journal-title":"Drugs"},{"key":"10.1016\/j.micpath.2026.108895_bib11","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00583-21","article-title":"Comparative analysis of pharmacodynamics in the C3HeB\/FeJ mouse tuberculosis model for DprE1 inhibitors TBA-7371, PBTZ169, and OPC-167832","volume":"65","author":"Robertson","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2026.108895_bib12","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02020-19","article-title":"OPC-167832, a novel carbostyril derivative with potent antituberculosis activity as a DprE1 inhibitor","volume":"64","author":"Hariguchi","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2026.108895_bib13","doi-asserted-by":"crossref","DOI":"10.1128\/aac.01477-22","article-title":"Phase I single ascending dose and food effect study in healthy adults and phase I\/IIa multiple ascending dose study in patients with pulmonary tuberculosis to assess pharmacokinetics, bactericidal activity, tolerability, and safety of OPC-167832","volume":"67","author":"Dawson","year":"2023","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2026.108895_bib14","doi-asserted-by":"crossref","DOI":"10.1128\/aac.01237-22","article-title":"Mycobacterium tuberculosis DprE1 inhibitor OPC-167832 is active against Mycobacterium abscessus in vitro","volume":"66","author":"Sarathy","year":"2022","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2026.108895_bib15","doi-asserted-by":"crossref","first-page":"4104","DOI":"10.1099\/ijsem.0.002261","article-title":"Mycobacterium aquiterrae sp. Nov., a rapidly growing bacterium isolated from groundwater","volume":"67","author":"Lee","year":"2017","journal-title":"Int. J. Syst. Evol. Microbiol."},{"key":"10.1016\/j.micpath.2026.108895_bib16","series-title":"Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes","author":"Woods","year":"2011"},{"key":"10.1016\/j.micpath.2026.108895_bib17","article-title":"In vitro and intracellular inhibitory activities of nosiheptide against Mycobacterium abscessus","volume":"13","author":"Zhu","year":"2022","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2026.108895_bib18","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00236-20","article-title":"AR-12 exhibits direct and host-targeted antibacterial activity toward Mycobacterium abscessus","volume":"64","author":"Zhang","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2026.108895_bib19","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.03859-23","article-title":"Discordant results between xpert MTB\/RIF assay and Bactec MGIT 960 culture system regarding the detection of rifampin-resistant Mycobacterium tuberculosis isolates in Wenzhou, China","volume":"12","author":"He","year":"2024","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.micpath.2026.108895_bib20","doi-asserted-by":"crossref","first-page":"4054","DOI":"10.1128\/AAC.00142-14","article-title":"In vivo assessment of drug efficacy against Mycobacterium abscessus using the embryonic zebrafish test system","volume":"58","author":"Bernut","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2026.108895_bib21","article-title":"Omadacycline potentiates clarithromycin activity against Mycobacterium abscessus","volume":"12","author":"Bich","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.micpath.2026.108895_bib22","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ijantimicag.2019.02.013","article-title":"In vitro activity of DNF-3 against drug-resistant Mycobacterium tuberculosis","volume":"54","author":"Islam","year":"2019","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.micpath.2026.108895_bib23","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00597-23","article-title":"Drug distribution and efficacy of the DprE1 inhibitor BTZ-043 in the C3HeB\/FeJ mouse tuberculosis model","volume":"67","author":"Ramey","year":"2023","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2026.108895_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1243457","article-title":"Non-tuberculous mycobacterial disease: progress and advances in the development of novel candidate and repurposed drugs","volume":"13","author":"Gu","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.micpath.2026.108895_bib25","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01314-18","article-title":"In vitro activity of PBTZ169 against multiple mycobacterium species","volume":"62","author":"Shi","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2026.108895_bib26","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00281-015-0522-4","article-title":"Protection and pathology in TB: learning from the zebrafish model","volume":"38","author":"Meijer","year":"2016","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.micpath.2026.108895_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1696204","article-title":"Molecular docking and dynamics in protein serine\/threonine kinase drug discovery: advances, challenges, and future perspectives","volume":"16","author":"Hasan","year":"2025","journal-title":"Front. Pharmacol."}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401026006212?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401026006212?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T05:33:15Z","timestamp":1792906395000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401026006212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":27,"alternative-id":["S0882401026006212"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2026.108895","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Activity of OPC-167832 against Mycobacterium abscessus and Mycobacterium chelonae: In vitro, intracellular, and in vivo assessment using a zebrafish infection model","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2026.108895","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108895"}}